EQS-Adhoc: Alzchem Group AG raises forecasts for EBITDA and EBITDA margin in fiscal year 2024


Werte in diesem Artikel
Aktien

159.80 EUR -0.60 EUR -0.37 %

EQS-Ad-hoc: AlzChem Group AG / Key word(s): Change in Forecast
Alzchem Group AG raises forecasts for EBITDA and EBITDA margin in fiscal year 2024

30-Jul-2024 / 09:21 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Werbung


Alzchem Group AG raises forecasts for EBITDA and EBITDA margin in fiscal year 2024

Trostberg, July 30, 2024 – Alzchem Group AG is raising its earnings forecasts for fiscal year 2024. Group EBITDA will grow to over EUR 100 million with unchanged sales expectations (original forecast: approx. EUR 90 million). The raise in the EBITDA forecast leads to an increase in the EBITDA margin forecast from previously approx. 15.8% to over 17.5%.

The reason for the increase in the EBITDA forecast is the stronger growth and thus the shift in the product mix towards Specialty Chemicals.

The previous forecasts for the financial performance indicators group sales, inventories, inventory intensity and equity ratio remain unchanged. This results in the following picture for fiscal year 2024:

  2023 Original forecast 2024 Adjusted forecast 2024
Group sales EUR 540.6 million Growing to around EUR 570 million Growing to around EUR 570 million
Adjusted EBITDA* EUR 81.4 million Growing to around EUR 90 million Growing to over EUR 100 million
Adjusted EBITDA margin* 15.1% Growing to 15.8% Growing to over 17.5%
Inventories EUR 107.5 million Stable Stable
Inventory intensity 19.9% Stable Stable
Equity ratio 38.5% Growing strongly Growing strongly
* No adjustments were made


End of Inside Information

Werbung

30-Jul-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Alzchem Group AG
Dr.-Albert-Frank-Str. 32
83308 Trostberg
Germany
Phone: +498621862888
Fax: +49862186502888
E-mail: ir@alzchem.com
Internet: www.alzchem.com
ISIN: DE000A2YNT30
WKN: A2YNT3
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart
EQS News ID: 1956527

 
End of Announcement EQS News Service

1956527  30-Jul-2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1956527&application_name=news&site_id=finanzen_net~~~069d1026-6a45-454f-953c-2a2c4451f1d6

Aktuelle Alzchem Group Aktie News

Werbung

Alzchem Group Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Alzchem Group nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
Datum Rating Analyst
04.08.26 Alzchem Group Buy Deutsche Bank AG
03.08.26 Alzchem Group Buy Warburg Research
31.07.26 Alzchem Group Buy Jefferies & Company Inc.
31.07.26 Alzchem Group Buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
30.07.26 Alzchem Group Buy Warburg Research

Information


Die Handels- und Depotfunktionen in diesem Broker Cockpit werden für Finanzinstrumente von der Finanzen.net Zero GmbH als vertraglich gebundener Vermittler der DonauCapital Wertpapier GmbH (§ 3 Abs. 2 WpIG) bereitgestellt; bei Kryptowerten werden die Handels- und Depotfunktionen in diesem Broker Cockpit ausschließlich von der DonauCapital Wertpapier GmbH bereitgestellt. Die Finanzen.net GmbH stellt ausschließlich den technischen Rahmen bereit und ist in die Wertpapier- und Kryptodienstleistung nicht einbezogen.